Do patterns of mental healthcare predict treatment failure in young people with schizophrenia? Evidence from an Italian population-based cohort study

被引:13
作者
Corrao, Giovanni [1 ]
Soranna, Davide [1 ]
Merlino, Luca [2 ]
Monzani, Emiliano [3 ]
Vigano, Caterina [4 ]
Lora, Antonio [5 ]
机构
[1] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Lab Healthcare Res & Pharmacoepidemiol, Milan, Italy
[2] Operat Unit Terr Hlth Serv, Milan, Italy
[3] Ca Granda Niguarda Hosp, Dept Mental Hlth, Milan, Italy
[4] Univ Milan, Dept Biomed & Clin Sci Luigi Sacco, Milan, Italy
[5] Lecco Hosp, Dept Mental Hlth, Lecce, Italy
关键词
HORMONE REPLACEMENT THERAPY; RISK; PERSISTENCE; DISORDERS; RELAPSE; GAP;
D O I
10.1136/bmjopen-2014-007140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Little is known about the practice of predicting community-based care effectiveness of patients affected by schizophrenic disorders. We assessed predictors of treatment failure in a large sample of young people affected by schizophrenia. Methods: A cohort of 556 patients aged 18-35 years who were originally diagnosed with schizophrenia during 2005-2009 in a Mental Health Service (MHS) of the Italian Lombardy Region was identified. Intensity of mental healthcare received during the first year after index visit (exposure) was measured by patients' regularity in MHS attendance and the length of time covered with antipsychotic drug therapy. Patients were followed from index visit until 2012 for identifying hospital admission for mental disorder (outcome). A proportional hazards model was fitted to estimate the HR and 95% CIs for the exposure-outcome association, after adjusting for several covariates. A set of sensitivity analyses were performed in order to account for sources of systematic uncertainty. Results: During follow-up, 144 cohort members experienced the outcome. Compared with patients on low coverage with antipsychotic drugs (<= 4 months), those on intermediate (5-8 months) and high (>= 9 months) coverage, had HRs (95% CI) of 0.94 (0.64 to 1.40) and 0.69 (0.48 to 0.98), respectively. There was no evidence that regular attendance at the MHS affected the outcome. Conclusions: Patients in the early phase of schizophrenia and their families should be cautioned about the possible consequences of poor antipsychotic adherence. Physicians and decision makers should increase their contribution towards improving mental healthcare.
引用
收藏
页数:9
相关论文
共 36 条
[1]  
[Anonymous], BR J PSYCH
[2]  
[Anonymous], ARCH GEN PSYCHIAT
[3]   Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey [J].
Barbui, C. ;
Conti, V. ;
Purgato, M. ;
Cipriani, A. ;
Fortino, I. ;
Rivolta, A. L. ;
Lora, A. .
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2013, 22 (04) :355-361
[4]   Neurocognitive impairment in schizophrenia and how it affects treatment options [J].
Bilder, RM .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1997, 42 (03) :255-264
[5]   The psychosocial treatment of schizophrenia: An update [J].
Bustillo, JR ;
Lauriello, J ;
Horan, WP ;
Keith, SJ .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (02) :163-175
[6]  
CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578
[7]  
Carter MJ, 2014, THER RECREAT J, V48, P275
[8]   The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients [J].
Charlson, Mary E. ;
Charlson, Robert E. ;
Peterson, Janey C. ;
Marinopoulos, Spyridon S. ;
Briggs, William M. ;
Hollenberg, James P. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (12) :1234-1240
[9]   Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments [J].
Chien, Wai Tong ;
Yip, Annie L. K. .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 :1311-1332
[10]   Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders [J].
Conti, Valentino ;
Lora, Antonio ;
Cipriani, Andrea ;
Fortino, Ida ;
Merlino, Luca ;
Barbui, Corrado .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (12) :1647-1655